Product Details
| Alternative Name: | 2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one |
| |
| Formula: | C19H24N2O2 |
| |
| MW: | 312.4 |
| |
| CAS: | 55268-74-1 |
| |
| MI: | 14: 7716 |
| |
| RTECS: | UQ4150000 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Appearance: | White to off-white powder. |
| |
| Solubility: | Soluble in 100% ethanol or chloroform; slightly soluble in water. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | Ambient |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
IL-10 Blocks the Development of Resistance to Re-Infection with Schistosoma mansoni: M.S. Wilson, et al.; PLoS Pathog.
7, e1002171 (2011),
Abstract;
Full Text
Therapy of parenchymal brain cysticercosis with praziquantel: J. Sotelo, et al.; New Engl. J. Med.
310, 1001 (1984),
Abstract;
Single dose oral treatment in urinary schistosomiasis: a double blind trial: R.N.H. Pugh & C.H. Teesdale; Brit. Med. J. (Clin Res Ed)
286, 429 (1983),
Abstract;
